© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#voxilaprevir

Vosevi

AbbVie and Gilead Get European Recommendation for New Hepatitis C Combos

Maviret and Vosevi were highly effective and well tolerated in clinical trials.

Gilead Files for FDA OK of New All-Genotype Hepatitis C Treatment

The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.

Excellent Results for Gilead’s Experimental Regimen for All Hep C Genotypes

Gilead has tested the addition of the investigational voxilaprevir to its already approved Epclusa (sofosbuvir/velpatasvir).
Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.